Peetz Christopher sold MIRM
July 6, 2026 · Form 4 insider transaction
Peetz Christopher sold 12,134 shares of Mirum Pharmaceuticals, Inc. at $121.65 per share, a transaction worth $1.48M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,134
Price
$121.65
Total value
$1.48M
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after202,175
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $121.65, and the range of prices were between $121.11 and $122.105. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.